Internal Medicine, Gastroenterology · Willmar, MN
NPI
1790741080
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
101 Willmar Ave SW, Affiliated Community Medical Centers
Willmar, MN, 56201
Phone (320) 231-5000
Medicare paid, 2024
$58K
5,020 services
Medicare patients, 2024
195
Average age 70
Drug cost, 2024
$1.3M
1,688 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles D Ulrich II was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 2,882 times for 23 patients. In total Charles D Ulrich II billed 5,020 services in 75 codes, and Medicare paid $58K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,882 | 23 | $0.10 | $297 |
| 36415 Venipuncture Blood Collection | Office | 270 | 157 | $8.65 | $2,336 |
| 80053 Clinical Chemistry | Office | 227 | 146 | $10.35 | $2,349 |
| 85025 Blood Count | Office | 224 | 144 | $7.61 | $1,705 |
| 86140 Clinical Chemistry | Office | 168 | 106 | $5.08 | $853 |
| 99214 Office E&M - Established | Office | 167 | 117 | $91.68 | $15K |
| A9585 Injection, gadobutrol, 0.1 ml | Office | 156 | 17 | $0.27 | $41.45 |
| 99213 Office E&M - Established | Office | 129 | 112 | $62.05 | $8,004 |
| 82150 Clinical Chemistry | Office | 85 | 59 | $6.35 | $540 |
| 83690 Clinical Chemistry | Office | 84 | 59 | $6.75 | $567 |
| 82784 Immunoassay | Office | 45 | 28 | $9.11 | $410 |
| 74177 CT/CTA - Abdomen and Pelvis | Office | 43 | 21 | $118.74 | $5,106 |
| 74183 MRI/MRA - Abdomen and Pelvis | Office | 36 | 18 | $128.67 | $4,632 |
| 82746 Clinical Chemistry | Office | 35 | 35 | $14.41 | $504 |
| 82607 Clinical Chemistry | Office | 34 | 34 | $14.78 | $503 |
By year: 2022 $114K for 8,788 services; 2023 $114K for 9,944 services; 2024 $58K for 5,020 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 270 | 157 | $8.65 | $2,336 |
| 80053 Clinical Chemistry | 227 | 146 | $10.35 | $2,349 |
| 85025 Blood Count | 224 | 144 | $7.61 | $1,705 |
| 86140 Clinical Chemistry | 168 | 106 | $5.08 | $853 |
| 82150 Clinical Chemistry | 85 | 59 | $6.35 | $540 |
| 83690 Clinical Chemistry | 84 | 59 | $6.75 | $567 |
| 82784 Immunoassay | 45 | 28 | $9.11 | $410 |
| 82746 Clinical Chemistry | 35 | 35 | $14.41 | $504 |
| 82607 Clinical Chemistry | 34 | 34 | $14.78 | $503 |
| 83516 Immunoassay | 32 | 16 | $11.30 | $362 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles D Ulrich II prescribed most often to Medicare patients was Famotidine, with 293 prescriptions and refills. In total Charles D Ulrich II wrote 1,688 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 293 | 433 | 73 | $2,397 |
| Omeprazole Generic | 251 | 404 | 67 | $4,001 |
| Creon Lipase/Protease/Amylase | 137 | 153 | 27 | $323K |
| Pantoprazole Sodium Generic | 119 | 188 | 29 | $1,503 |
| Linzess Linaclotide | 72 | 91 | 14 | $44K |
| Sucralfate Generic | 66 | 97 | 21 | $2,033 |
| Azithromycin Generic | 63 | 71 | 11 | $1,070 |
| Loperamide Loperamide Hcl | 62 | 62 | 23 | $1,473 |
| Budesonide Dr Budesonide | 53 | 86 | 19 | $15K |
| Ursodiol Generic | 49 | 63 | 11 | $4,692 |
| Cholestyramine Cholestyramine (With Sugar) | 47 | 56 | 13 | $2,484 |
| Balsalazide Disodium Generic | 34 | 40 | Under 11 | $6,414 |
| Mercaptopurine Generic | 31 | 37 | Under 11 | $2,377 |
| Lactulose Generic | 25 | 26 | Under 11 | $452 |
| Cimetidine Generic | 23 | 23 | Under 11 | $344 |
Brand drugs: 315 claims; generic drugs: 1,373 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Charles D Ulrich II were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.